Skip to main content
Clinical Trials/IRCT138904174306N1
IRCT138904174306N1
Completed
Phase 3

Adding Metformin to Clomiphen to improve ovulation rate in Clomiphen resistant women with polycystic ovarian syndrome: A randomized clinical trial study

Vice chanceller of Research and Technology of Babol University of medical sciences0 sites334 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Polycystic ovarian syndrom.
Sponsor
Vice chanceller of Research and Technology of Babol University of medical sciences
Enrollment
334
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chanceller of Research and Technology of Babol University of medical sciences

Eligibility Criteria

Inclusion Criteria

  • 1\. Infertile patients with PCOS. 2\. Normal values of TSH and prolactin 3\. Normal creatinin level 4\. Normal liver function (SGOT, SGPT). Exclusion criteria: 1\. hyperprolactinemia 2\. thyroid disease 3\.endometriosis 4\. tubal factor 5\. male factor 6\. metformin with side effect background 7\. diabetes mellitus.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials